285 related articles for article (PubMed ID: 26230099)
21. Role of GM-CSF in the inflammatory cytokine network that regulates neutrophil influx into the colonic mucosa during Clostridium difficile infection in mice.
McDermott AJ; Frank CR; Falkowski NR; McDonald RA; Young VB; Huffnagle GB
Gut Microbes; 2014 Jul; 5(4):476-84. PubMed ID: 25045999
[TBL] [Abstract][Full Text] [Related]
22. Recurrent Clostridioides difficile Infection Is Associated With Impaired T Helper Type 17 Immunity to C difficile Toxin B.
Cook L; Rees WD; Wong MQ; Kwok WW; Levings MK; Steiner TS
Gastroenterology; 2021 Mar; 160(4):1410-1413.e4. PubMed ID: 33253683
[No Abstract] [Full Text] [Related]
23. Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.
Abernathy-Close L; Dieterle MG; Vendrov KC; Bergin IL; Rao K; Young VB
Infect Immun; 2020 May; 88(6):. PubMed ID: 32284366
[No Abstract] [Full Text] [Related]
24. Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.
Zhang L; Dong D; Jiang C; Li Z; Wang X; Peng Y
Anaerobe; 2015 Aug; 34():1-7. PubMed ID: 25817005
[TBL] [Abstract][Full Text] [Related]
25. Nonsteroidal Anti-inflammatory Drugs Alter the Microbiota and Exacerbate
Maseda D; Zackular JP; Trindade B; Kirk L; Roxas JL; Rogers LM; Washington MK; Du L; Koyama T; Viswanathan VK; Vedantam G; Schloss PD; Crofford LJ; Skaar EP; Aronoff DM
mBio; 2019 Jan; 10(1):. PubMed ID: 30622186
[No Abstract] [Full Text] [Related]
26. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.
Markey L; Shaban L; Green ER; Lemon KP; Mecsas J; Kumamoto CA
Gut Microbes; 2018 Nov; 9(6):497-509. PubMed ID: 29667487
[TBL] [Abstract][Full Text] [Related]
27. Clostridioides difficile Infection Induces an Inferior IgG Response to That Induced by Immunization and Is Associated with a Lack of T Follicular Helper Cell and Memory B Cell Expansion.
Amadou Amani S; Shadid T; Ballard JD; Lang ML
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871095
[TBL] [Abstract][Full Text] [Related]
28. Role of interleukin 23 signaling in Clostridium difficile colitis.
Buonomo EL; Madan R; Pramoonjago P; Li L; Okusa MD; Petri WA
J Infect Dis; 2013 Sep; 208(6):917-20. PubMed ID: 23776194
[TBL] [Abstract][Full Text] [Related]
29.
Cheng JKJ; Unnikrishnan M
Microbiology (Reading); 2023 Feb; 169(2):. PubMed ID: 36848200
[No Abstract] [Full Text] [Related]
30. Effects of β-lactam antibiotics and fluoroquinolones on human gut microbiota in relation to Clostridium difficile associated diarrhea.
Knecht H; Neulinger SC; Heinsen FA; Knecht C; Schilhabel A; Schmitz RA; Zimmermann A; dos Santos VM; Ferrer M; Rosenstiel PC; Schreiber S; Friedrichs AK; Ott SJ
PLoS One; 2014; 9(2):e89417. PubMed ID: 24586762
[TBL] [Abstract][Full Text] [Related]
31. Effects of heat-killed Enterococcus faecalis T-110 supplementation on gut immunity, gut flora, and intestinal infection in naturally aged hamsters.
Inatomi T; Otomaru K
PLoS One; 2020; 15(12):e0240773. PubMed ID: 33378402
[TBL] [Abstract][Full Text] [Related]
32. Dissecting Individual Interactions between Pathogenic and Commensal Bacteria within a Multispecies Gut Microbial Community.
Hassall J; Cheng JKJ; Unnikrishnan M
mSphere; 2021 Mar; 6(2):. PubMed ID: 33762315
[TBL] [Abstract][Full Text] [Related]
33.
Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R
mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404
[TBL] [Abstract][Full Text] [Related]
34. Modeling new immunoregulatory therapeutics as antimicrobial alternatives for treating Clostridium difficile infection.
Leber A; Hontecillas R; Abedi V; Tubau-Juni N; Zoccoli-Rodriguez V; Stewart C; Bassaganya-Riera J
Artif Intell Med; 2017 May; 78():1-13. PubMed ID: 28764868
[TBL] [Abstract][Full Text] [Related]
35. The role of gut microbiota in Clostridium difficile infection.
Samarkos M; Mastrogianni E; Kampouropoulou O
Eur J Intern Med; 2018 Apr; 50():28-32. PubMed ID: 29428498
[TBL] [Abstract][Full Text] [Related]
36. [Interactions between intestinal microbiota and Clostridioides difficile].
Barbut F; Couturier J
Rev Prat; 2019 Sep; 69(7):784-791. PubMed ID: 32233325
[TBL] [Abstract][Full Text] [Related]
37. Critical role for MyD88-mediated neutrophil recruitment during Clostridium difficile colitis.
Jarchum I; Liu M; Shi C; Equinda M; Pamer EG
Infect Immun; 2012 Sep; 80(9):2989-96. PubMed ID: 22689818
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile infection and intestinal microbiota interactions.
Rodriguez C; Taminiau B; Van Broeck J; Delmée M; Daube G
Microb Pathog; 2015 Dec; 89():201-9. PubMed ID: 26549493
[TBL] [Abstract][Full Text] [Related]
39. Disease Progression and Resolution in Rodent Models of Clostridium difficile Infection and Impact of Antitoxin Antibodies and Vancomycin.
Warn P; Thommes P; Sattar A; Corbett D; Flattery A; Zhang Z; Black T; Hernandez LD; Therien AG
Antimicrob Agents Chemother; 2016 Nov; 60(11):6471-6482. PubMed ID: 27527088
[TBL] [Abstract][Full Text] [Related]
40. In vivo commensal control of Clostridioides difficile virulence.
Girinathan BP; DiBenedetto N; Worley JN; Peltier J; Arrieta-Ortiz ML; Immanuel SRC; Lavin R; Delaney ML; Cummins CK; Hoffman M; Luo Y; Gonzalez-Escalona N; Allard M; Onderdonk AB; Gerber GK; Sonenshein AL; Baliga NS; Dupuy B; Bry L
Cell Host Microbe; 2021 Nov; 29(11):1693-1708.e7. PubMed ID: 34637781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
